EP3215527
Mannaðlöguð and-magnaþáttar C1q mótefni og notkun á þeim
:
EP einkaleyfi í gildi á Íslandi:
5.11.2015:
8.1.2025:
15857258.6
:
10.3.2025:
15.4.2025
:
4.11.2035:
4.11.2025
:
HUMANIZED ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF
5.11.2015
8.1.2025
10.3.2025
15.4.2025
4.11.2025
:
Annexon, Inc.:
1400 Sierra Point Parkway Building C, 2nd Floor, Brisbane, CA 94005, US
:
ROSENTHAL, Arnon:
Woodside, CA 94062, US
:
LEVITEN, Michael:
Emerald Hills, CA 94062, US
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
201462075793 P:
5.11.2014:
US
:
US2015059185:
5.11.2015
:
C07K 16/18, A61K 39/395, A61K 49/00, A61K 49/16, G01N 33/564, G01N 33/68, A61P 3/00, A61P 3/04, A61P 3/10, A61P 7/06, A61P 9/10, A61P 21/04, A61P 25/00, A61P 25/14, A61P 25/16, A61P 25/28, A61P 29/00, A61P 35/00, A61P 37/02, A61P 37/06